• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding COVID-19 in Africa.了解非洲的 COVID-19 疫情。
Nat Rev Immunol. 2021 Aug;21(8):469-470. doi: 10.1038/s41577-021-00579-y. Epub 2021 Jun 24.
2
Balancing the Risks and Benefits of COVID-19 Vaccination for Pregnant Women and Their Children.权衡孕妇及其子女接种新冠疫苗的风险与益处
Front Immunol. 2021 Dec 16;12:748456. doi: 10.3389/fimmu.2021.748456. eCollection 2021.
3
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants.COVID-19 疫苗:紧跟 SARS-CoV-2 变异株。
Cell. 2021 Sep 30;184(20):5077-5081. doi: 10.1016/j.cell.2021.09.010. Epub 2021 Sep 17.
4
How severe are Omicron infections?奥密克戎感染有多严重?
Nature. 2021 Dec;600(7890):577-578. doi: 10.1038/d41586-021-03794-8.
5
Lessons Relearned? H1N1, COVID-19, and Vaccination Planning.吸取的教训?甲型H1N1流感、新冠疫情与疫苗接种规划。
J Public Health Manag Pract. 2021 Jan/Feb;27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving Forward:S106-S110. doi: 10.1097/PHH.0000000000001289.
6
Covid-19 eradication: stopping transmission between countries.新冠疫情根除:阻止国家间传播。
BMJ. 2021 Jun 7;373:n1425. doi: 10.1136/bmj.n1425.
7
The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers' unvaccinated household members.mRNA 新冠疫苗接种对医护人员未接种疫苗的家庭成员的间接影响。
Nat Commun. 2022 Mar 4;13(1):1162. doi: 10.1038/s41467-022-28825-4.
8
Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon.核心概念:群体免疫是一种重要且常被误解的公共卫生现象。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2107692118.
9
The long road.漫长的道路。
Science. 2021 Feb 19;371(6531):768-772. doi: 10.1126/science.371.6531.768.
10
Will Omicron end the pandemic? Here's what experts say.奥密克戎会终结这场大流行吗?以下是专家们的看法。
Nature. 2022 Feb;602(7895):20-21. doi: 10.1038/d41586-022-00210-7.

引用本文的文献

1
High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad.乍得首都抗新冠病毒抗体的高血清阳性率。
J Public Health Afr. 2023 Jan 11;13(4):2255. doi: 10.4081/jphia.2022.2255. eCollection 2022 Dec 31.
2
Overcoming Vaccine Inequities and Research Gaps in Africa: Challenges and Opportunities Identified During the COVID-19 Pandemic.克服非洲疫苗不平等和研究差距:新冠疫情期间发现的挑战与机遇
Clin Infect Dis. 2025 Jul 22;80(Supplement_1):S9-S15. doi: 10.1093/cid/ciaf055.
3
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study.加纳成年人在完成新冠疫苗基础免疫后产生的中和抗体滴度高于且比英国匹配的成年人更持久:HERITAGE研究。
BMC Med. 2025 May 28;23(1):312. doi: 10.1186/s12916-025-04157-0.
4
"Everything had stopped, no meeting, no gathering": Social interactions during the COVID-19 pandemic in the Central African Republic, the Democratic Republic of Congo, and Bangladesh.“一切都停止了,没有会议,没有聚会”:中非共和国、刚果民主共和国和孟加拉国在新冠疫情期间的社交互动
PLoS One. 2025 May 27;20(5):e0323108. doi: 10.1371/journal.pone.0323108. eCollection 2025.
5
Seroprevalence and demographic characteristics of SARS-CoV-2-infected residents of Kibera informal settlement during the COVID-19 pandemic in Nairobi, Kenya: a cross-sectional study.肯尼亚内罗毕新冠疫情期间基贝拉非正式定居点感染新冠病毒居民的血清流行率及人口统计学特征:一项横断面研究
BMJ Open. 2025 Apr 2;15(4):e094546. doi: 10.1136/bmjopen-2024-094546.
6
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon.喀麦隆个体感染新型冠状病毒后针对刺突蛋白的纵向体液免疫
Virology. 2025 Apr;605:110467. doi: 10.1016/j.virol.2025.110467. Epub 2025 Feb 25.
7
Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter.恩贾梅纳地区新冠病毒毒株的血清流行率与基于基因组的综合研究:对乍得新冠疫情中心的洞察
J Med Virol. 2025 Feb;97(2):e70234. doi: 10.1002/jmv.70234.
8
Pre-pandemic cross-reactive antibody and cellular responses against SARS-CoV-2 among female sex workers in Dakar, Senegal.塞内加尔达喀尔女性性工作者中疫情前针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的交叉反应性抗体及细胞免疫反应
Front Public Health. 2025 Jan 23;13:1522733. doi: 10.3389/fpubh.2025.1522733. eCollection 2025.
9
Seroprevalence of SARS-CoV-2 and risk factors for infection among children in Uganda: A serial cross-sectional study.乌干达儿童中新冠病毒血清流行率及感染风险因素:一项系列横断面研究
PLoS One. 2024 Dec 23;19(12):e0312554. doi: 10.1371/journal.pone.0312554. eCollection 2024.
10
The impact of COVID-19 mitigation measures on neonatal health outcomes in sub-Saharan Africa: A systematic review and meta-analysis.新冠疫情缓解措施对撒哈拉以南非洲地区新生儿健康结局的影响:一项系统评价与荟萃分析
Public Health. 2025 Jan;238:108-116. doi: 10.1016/j.puhe.2024.11.022. Epub 2024 Dec 5.

本文引用的文献

1
Sero-surveillance for IgG to SARS-CoV-2 at antenatal care clinics in three Kenyan referral hospitals: Repeated cross-sectional surveys 2020-21.肯尼亚三家转诊医院产前护理诊所的 SARS-CoV-2 IgG 血清监测:2020-21 年重复横断面调查。
PLoS One. 2022 Oct 14;17(10):e0265478. doi: 10.1371/journal.pone.0265478. eCollection 2022.
2
The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.非洲的 COVID-19 大流行的第一波和第二波:一项横断面研究。
Lancet. 2021 Apr 3;397(10281):1265-1275. doi: 10.1016/S0140-6736(21)00632-2. Epub 2021 Mar 24.
3
SARS-CoV-2 and common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)与常见免疫显性区域或许可以解释疟疾流行带中新冠病毒疾病(COVID-19)发病率较低的现象。
New Microbes New Infect. 2020 Nov;38:100817. doi: 10.1016/j.nmni.2020.100817. Epub 2020 Nov 19.
4
Comorbidities and the COVID-19 pandemic dynamics in Africa.非洲的合并症与 COVID-19 大流行动态。
Trop Med Int Health. 2021 Jan;26(1):2-13. doi: 10.1111/tmi.13504. Epub 2020 Oct 23.
5
Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.南非西开普省人群队列研究中 2019 冠状病毒病(COVID-19)死亡的危险因素。
Clin Infect Dis. 2021 Oct 5;73(7):e2005-e2015. doi: 10.1093/cid/ciaa1198.
6
SeroTracker: a global SARS-CoV-2 seroprevalence dashboard.血清追踪器:一个全球新冠病毒血清流行率信息平台。
Lancet Infect Dis. 2021 Apr;21(4):e75-e76. doi: 10.1016/S1473-3099(20)30631-9. Epub 2020 Aug 4.
7
Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts.结核病、COVID-19 和移民:对两个队列中 69 例死亡患者的初步分析。
Pulmonology. 2020 Jul-Aug;26(4):233-240. doi: 10.1016/j.pulmoe.2020.05.002. Epub 2020 May 14.

了解非洲的 COVID-19 疫情。

Understanding COVID-19 in Africa.

机构信息

Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia.

出版信息

Nat Rev Immunol. 2021 Aug;21(8):469-470. doi: 10.1038/s41577-021-00579-y. Epub 2021 Jun 24.

DOI:10.1038/s41577-021-00579-y
PMID:34168345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8222946/
Abstract

The coronavirus disease 2019 (COVID-19) pandemic has spread to all 55 countries in Africa. The prevalence is highly heterogeneous, and the majority of cases are asymptomatic. Several factors are thought to explain heterogeneity of COVID-19 in Africa, including the level of containment measures, demographic aspects, climate and environmental factors, host genetics and immune factors. Here, we discuss the prevalence of COVID-19 in Africa, the status of serological studies, COVID-19 and comorbidities, as well as the spread of SARS-CoV-2 variants and the status of vaccine roll-outs in Africa.

摘要

2019 年冠状病毒病(COVID-19)大流行已蔓延至非洲的 55 个国家。该病的流行情况差异很大,多数病例为无症状。人们认为有几个因素可以解释非洲 COVID-19 存在差异,包括遏制措施的水平、人口统计学方面、气候和环境因素、宿主遗传和免疫因素。在此,我们讨论了 COVID-19 在非洲的流行情况、血清学研究现状、COVID-19 与合并症、SARS-CoV-2 变异株的传播以及非洲疫苗接种情况。